OKT3 and IL-2 treatment for purging of the latent HIV-1 reservoir in vivo results in selective long-lasting CD4+ T cell depletion. (Q52019286)

19 April 2018

title

OKT3 and IL-2 treatment for purging of the latent HIV-1 reservoir in vivo results in selective long-lasting CD4+ T cell depletion. (English)

1 reference

19 April 2018

author name string

R M van Praag

1

1 reference

19 April 2018

J M Prins

2

1 reference

19 April 2018

M T Roos

3

1 reference

19 April 2018

P T Schellekens

4

1 reference

19 April 2018

I J Ten Berge

5

1 reference

19 April 2018

S L Yong

6

1 reference

19 April 2018

H Schuitemaker

7

1 reference

19 April 2018

A J Eerenberg

8

1 reference

19 April 2018

S Jurriaans

9

1 reference

19 April 2018

F de Wolf

10

1 reference

19 April 2018

C H Fox

11

1 reference

19 April 2018

J Goudsmit

12

1 reference

19 April 2018

F Miedema

13

1 reference

19 April 2018

J M Lange

14

1 reference

19 April 2018

publication date

1 May 2001

1 reference

19 April 2018

Journal of Clinical Immunology

published in

1 reference

19 April 2018

volume

21

1 reference

19 April 2018

issue

3

1 reference

19 April 2018

page(s)

218-226

1 reference

19 April 2018

https://scigraph.springernature.com/pub.10.1023/a:1011091300321

exact match

0 references

cites work

Biphasic granulocytopenia after administration of the first dose of OKT3

1 reference

12 December 2020

Phenotypic and functional separation of memory and effector human CD8+ T cells

1 reference

12 December 2020

Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. A preliminary study

1 reference

12 December 2020

Reduction of the HIV-1-infected T-cell reservoir by immune activation treatment is dose-dependent and restricted by the potency of antiretroviral drugs.

1 reference

12 December 2020

Persistent long-term changes in lymphocyte subsets induced by polyclonal antibodies

1 reference

12 December 2020

Toxicity of OKT3 increases with dosage: a controlled study in renal transplant recipients

1 reference

12 December 2020

Subcutaneous administration of interleukin-2 in human immunodeficiency virus type 1-infected persons

1 reference

12 December 2020

In vivo cell activation following OKT3 administration. Systemic cytokine release and modulation by corticosteroids

1 reference

12 December 2020

Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy

1 reference

12 December 2020

Initial increase in blood CD4(+) lymphocytes after HIV antiretroviral therapy reflects redistribution from lymphoid tissues.

1 reference

12 December 2020

Activation of human T cells in vivo following treatment of transplant recipients with OKT3.

1 reference

12 December 2020

HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time

1 reference

12 December 2020

Administration of OKT3 as a two-hour infusion attenuates first-dose side effects

1 reference

12 December 2020

The mechanism of anti-CD3 monoclonal antibodies. Mediation of cytolysis by inter-T cell bridging

1 reference

12 December 2020

Reduction of morbidity and cytokine release in anti-CD3 MoAb-treated mice by corticosteroids

1 reference

12 December 2020

Immunosuppression by OKT3--induction of programmed cell death (apoptosis) as a possible mechanism of action

1 reference

12 December 2020

Toward HIV eradication or remission: the tasks ahead

1 reference

12 December 2020

Recovery of replication-competent HIV despite prolonged suppression of plasma viremia

1 reference

12 December 2020

Chemokines--chemotactic cytokines that mediate inflammation

1 reference

12 December 2020

Activation and increased expression of adhesion molecules on peripheral blood lymphocytes is a mechanism for the immediate lymphocytopenia after administration of OKT3

1 reference

12 December 2020

In vivo anti-CD3-driven cell activation. Cellular source of induced tumor necrosis factor, interleukin-1 beta, and interleukin-6

1 reference

12 December 2020

Release of tumor necrosis factor, interleukin-2, and gamma-interferon in serum after injection of OKT3 monoclonal antibody in kidney transplant recipients

1 reference

12 December 2020

Treatment with depleting CD4 monoclonal antibody results in a preferential loss of circulating naive T cells but does not affect IFN-gamma secreting TH1 cells in humans

1 reference

12 December 2020

Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy

1 reference

12 December 2020

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy

1 reference

12 December 2020

Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy

1 reference

12 December 2020

OKT3 monoclonal antibody plasma levels during therapy and the subsequent development of host antibodies to OKT3

1 reference

12 December 2020

A randomized clinical trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants

1 reference

12 December 2020

Essential role of the thymus to reconstitute naive (CD45RA+) T-helper cells after human allogeneic bone marrow transplantation

1 reference

12 December 2020

Triggering of the T3-Ti antigen-receptor complex results in clonal T-cell proliferation through an interleukin 2-dependent autocrine pathway

1 reference

12 December 2020

CD8+ lymphocyte activation at human immunodeficiency virus type 1 seroconversion: development of HLA-DR+ CD38- CD8+ cells is associated with subsequent stable CD4+ cell levels. The Multicenter AIDS Cohort Study Group

1 reference

12 December 2020

Distinctions between CD8+ and CD4+ T-cell regenerative pathways result in prolonged T-cell subset imbalance after intensive chemotherapy.

1 reference

12 December 2020

Induction of HIV-1 replication in latently infected CD4+ T cells using a combination of cytokines

1 reference

12 December 2020

Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus

1 reference

12 December 2020

OKT3 first-dose reaction: association with T cell subsets and cytokine release

1 reference

12 December 2020

Recovery of T cell subsets after autologous bone marrow transplantation is mainly due to proliferation of mature T cells in the graft

1 reference

12 December 2020

Immuno-activation with anti-CD3 and recombinant human IL-2 in HIV-1-infected patients on potent antiretroviral therapy

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1011091300321

1 reference

19 April 2018

1 reference

19 April 2018